← Leaderboards
John Riley Lever
Johns Hopkins University
$1,109,181
Attributed
$1,109,181
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $344.2K · FY2009–14$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,109,181 · 3
By mechanism
RC1$678,643 · 1
R21$300,510 · 1
R01$130,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Martin G Pomper$38,517,075
- Mary E McCaul$21,975,059
- Jeffrey R Kirsch$2,094,977
- Richard J Traystman$6,198,678
- Claudia Michelle Campbell$14,946,130
Others in their field
Top investigators on “Public Health Relevance”
- James Dennis Neaton · Northwestern University$207,438,295
- Sharon A Nachman · Johns Hopkins University$197,601,947
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,622,842
- Jeffrey P Krischer · University Of South Florida$163,793,528
- George R Seage · Abt Associates, Inc.$128,298,055
- Harry P Selker · Virginia Commonwealth University$123,247,735
Research focus
Public Health RelevanceLigandsLaboratoriesPropertyTomography, Emission-Computed, Single-PhotonDesignClinicLabelPeripheralPositron-Emission TomographyReceptorBinding (Molecular Function)RadioligandPharmaceutical PreparationsBrainAffinityInnovationIn VivoLaboratory StudyDrug CandidateAttenuatedDrug Of AbuseCerebrumBehavior Observation
Grant awards (5)
Targeting Mu Opioid Receptors in non-Small Cell Lung Cancer$134,391
R21 · FY2014 · CA · contact PI
Targeting Mu Opioid Receptors in non-Small Cell Lung Cancer$166,119
R21 · FY2013 · CA · contact PI
Development of Anti-Cocaine Medications$344,174
RC1 · FY2010 · DA · contact PI
Development of Anti-Cocaine Medications$334,469
RC1 · FY2009 · DA · contact PI
3H AND 125I LABELED DELTA OPIOID RECEPTOR LIGANDS$130,028
R01 · FY2000 · DA